Please assess the completion status of the following clinical trial:

Trial Title: Renal Magnetic Resonance Angiography (MRA) Study Comparing Dotarem and Time Of Flight (TOF)

Study Design Characteristics:
- Allocation: NON_RANDOMIZED
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: DIAGNOSTIC
- Time Perspective: None
- Masking: NONE
- Phase: PHASE3
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Male or female, aged more than 18 years,~* Strongly suspected of having renal arterial disease,~* Scheduled (or to be scheduled) to undergo arterial catheter-based X-ray angiography examination,~Exclusion Criteria:~* Known grade IV or V chronic kidney disease (GFR\<30 mL/min/1.73m²),~* Contraindication to MRI,~* Acute renal dysfunction within the 6 months preceding Dotarem®-enhanced MRA examination,

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Dotarem (Type: EXPERIMENTAL): Each subject will receive one injection of Dotarem 0.2 ml/kg.
- Time Of Flight Magnetic Resonance Angiography (Type: OTHER): Each subject undergo a TOF MRA

Based on this trial design, predict the completion outcome and termination type (if applicable).